文献速递心血管MR

微血管阻塞范围预测射血分数保留的急性心肌梗死患者主要不良心血管事件

Microvascular obstruction extent predicts major adverse cardiovascular events in patients with acute myocardial infarction and preserved ejection fraction.
PubMed 文献 · Eur Radiol · 2018-12-14

纳入77例急诊PCI后LVEF>50%的STEMI患者,于梗死平均5天行CMR并随访5年。仅晚期微血管阻塞(MVO)的存在及范围在MACE与无MACE组间有显著差异;晚期MVO范围>0.385 g为MACE的强独立预测因子(敏感度87%,特异度90%,HR 2.24)。

要点

  • 晚期MVO范围>0.385 g预测5年MACE的敏感度87%、特异度90%,AUC 0.89。
  • MACE组晚期MVO存在比例50% vs 无MACE组16%,范围2.30±1.64 g vs 0.18±0.12 g。
  • 其余CMR组织标志物在MACE与无MACE组间均无显著差异。

核心结论

  • 急诊PCI后CMR显示的晚期MVO范围似乎是LVEF>50%的STEMI患者5年随访MACE的强预测因子。
  • 晚期MVO范围>0.385 g提供了相关预后信息,有助于改善长期风险分层。

研究设计与样本

  • 纳入77例接受直接PCI且CMR示LVEF>50%的STEMI患者。
  • STEMI至CMR的中位时间为5天(IQR 2-8天)。
  • 检测并测量左室容积与功能、T2加权图像上的危险区、晚期增强图像上的梗死心肌、心肌内出血及早期和晚期MVO。
  • 将CMR组织标志物与5年随访期间MACE发生率进行相关性分析。

关键影像表现/征象

  • T2加权图像用于评估危险区,晚期增强图像用于评估梗死心肌及晚期MVO。
  • MACE组晚期MVO存在比例为50%,无MACE组为16%(p=0.044)。
  • MACE组晚期MVO范围为2.30±1.64 g,无MACE组为0.18±0.12 g(p=0.000)。
  • 除晚期MVO的存在及范围外,其余CMR组织标志物在MACE与无MACE组间均无显著差异。

诊断标准与关键数值

  • 晚期MVO范围>0.385 g预测MACE:ROC曲线AUC 0.89(95%CI 0.75-1.0,p=0.000),敏感度87%,特异度90%,HR 2.24(95%CI 1.51-3.33,p=0.000)。
  • 中位随访4年(范围3至5年)期间,8例(10%)患者发生MACE,年化事件率为2.1%。

临床应用与阅片要点

  • 对急诊PCI后LVEF>50%的STEMI患者,可测量晚期增强图像上的晚期MVO范围以辅助长期风险分层。
  • 晚期MVO范围>0.385 g提示MACE风险升高(HR 2.24),可据此识别高危患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the prognostic role of early post-infarction cardiac magnetic resonance (CMR) on long-term risk stratification of ST segment elevation myocardial infarction (STEMI) patients with preserved left ventricular ejection fraction (LVEF).

METHODS: Seventy-seven STEMI patients treated by primary percutaneous coronary intervention (PCI) and LVEF > 50% at CMR were included. The median time between STEMI and CMR was 5 days (IQR 2-8). LV volumes and function, area at risk (on T2 weighted images), infarcted myocardium (on late enhanced images), intramyocardial hemorrhage, and early and late microvascular obstruction (MVO) were detected and measured. CMR tissue determinants were correlated with the incidence of major adverse cardiovascular events (MACEs) over a 5-year follow-up.

RESULTS: During median follow-up of 4 years (range 3 to 5 years), eight (10%) patients experienced MACE, yielding an annualized event rate of 2.1%. All CMR tissue markers were not significantly different between MACE and no-MACE patients, except for the presence of late MVO (50% vs. 16%, respectively; p = 0.044) and its extent (2.30 ± 1.64 g vs. 0.18 ± 0.12 g, respectively; p = 0.000). From receiver-operating characteristic (ROC) curve (area under the curve 0.89; 95% confidence interval, 0.75-1.0; p = 0.000), late MVO extent > 0.385 g was a strong independent predictor of MACE at long-term follow-up (sensitivity = 87%, specificity = 90%; hazard ratio = 2.24; 95% confidence interval, 1.51-3.33; p = 0.000).

CONCLUSIONS: Late MVO extent after primary PCI on CMR seems to be a strong predictor of MACE at 5-year follow-up in patients with LVEF > 50%. Noticeably, late MVO extent > 0.385 g provided relevant prognostic insights leading to improved long-term risk stratification.

KEY POINTS: • Tissue markers provided by cardiac magnetic resonance aid in prognostic stratification after myocardial infarction • The occurrence of late microvascular obstruction after acute myocardial infarction increases risk of major adverse events at 5-year follow-up. • The greater microvascular obstruction extent on late gadolinium enhanced images is related to an increased risk of adverse events in patients with myocardial infarction and preserved left ventricular function.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Galea N, Dacquino GM, Ammendola RM, et al. Microvascular obstruction extent predicts major adverse cardiovascular events in patients with acute myocardial infarction and preserved ejection fraction. Eur Radiol. 2018. PMID: 30552479. doi:10.1007/s00330-018-5895-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。